AbClon Inc.
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
174900 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 구로구 디지털로 285 에이스트윈타워 1차 1401호, 구로구
- Website:
- https://www.abclon.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
AbClon Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel antibody-based therapeutics, primarily for oncology. The company's core technological assets include the CAR-T platform for personalized cancer immunotherapies, the NEST (Novel Epitope Screening Technology) platform for discovering antibodies against unique epitopes on disease proteins, and the AffiMab platform for the agile development of bispecific antibodies. These platforms are designed to address refractory diseases by creating treatments with novel therapeutic effects. In addition to its therapeutic pipeline, AbClon provides contract research organization (CRO) services, including antibody production and purification.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for AbClon Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all AbClon Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for AbClon Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
